At a glance
- Originator Ono Pharmaceutical
- Class Antineoplastics; Lipopolysacchrides
- Mechanism of Action Tumour necrosis factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer